Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate whether patients with severe eosinophilic asthma who have received longterm treatment with mepolizumab (at least 3 years) need to maintain treatment with mepolizumab to continue to receive benefit.
Inclusion criteria
- Severe Eosinophilic Asthma